Key facts
- This page summarizes Adi Mor George's Form 3 filing for Chemomab Therapeutics Ltd. (CMMB).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 10 Apr 2026, 16:15.
Adi Mor George - 18 Mar 2026 Form 3 Insider Report for Chemomab Therapeutics Ltd. (CMMB)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CMMB
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Apr 2026, 16:15:00 UTC
- Prior SEC filing
- 05 Jan 2023
- Next SEC filing
- 01 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adi Mor
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Adi Mor George filed Form 3 for Chemomab Therapeutics Ltd. (CMMB) on 10 Apr 2026.
Change
- Previous filing in this sequence was filed on 05 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001851069
Primary reporting owner
Mor George Adi
- Relationship
- Chief Executive Officer, Director
- Address
- C/O CHEMOMAB THERAPEUTICS LTD., 10 HABARZEL ST., BUILDING C, 10TH FLOOR, TEL AVIV, ISRAEL
- Signature
- /s/ Adi Mor
- Signature date
- 10 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMMB
holding
American Depositary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 79,268
- Date
- 18 Mar 2026
- Ownership
- Direct
CMMB
holding
American Depositary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,059
- Date
- 18 Mar 2026
- Ownership
- Securities held by the Reporting Person's spouse.
CMMB
holding
American Depositary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 31,712
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
CMMB
holding
American Depositary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,750
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMMB
holding
Derivative
Stock option (right to buy American Depositary Shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 32,925
- Exercise price
- $5.94
- Footnotes
- F3
CMMB
holding
Derivative
Stock option (right to buy American Depositary Shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 109,718
- Exercise price
- $5.16
- Footnotes
- F4
CMMB
holding
Derivative
Stock option (right to buy American Depositary Shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Securities held by the Reporting Person's spouse.
- Underlying class
- American Depositary Shares
- Underlying amount
- 8,431
- Exercise price
- $3.20
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The American Depositary Shares reported in this row consist of restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer on November 18, 2024, and vest and become exercisable according to following schedule: 25% on October 1, 2025, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on October 1, 2028.
Footnote F2
The American Depositary Shares reported in this row consist of RSUs that were granted to the Reporting Person by the Issuer on July 1, 2025 vest and become exercisable according to following schedule: 25% on April 10, 2026, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on April 10, 2029.
Footnote F3
The options reported in this row were granted to the Reporting Person by the Issuer on March 15, 2018, and are fully vested and exercisable as of the date of this report.
Footnote F4
The options reported in this row were granted to the Reporting Person by the Issuer on June 14, 2023, and vest and become exercisable according to following schedule: 25% on June 1, 2024, thereafter, in 12 equal quarterly installments of 6.25%, such that all options reported in this row will be exercisable on June 1, 2027.
Footnote F5
The options reported in this row were granted to the Reporting Person's spouse by the Issuer on October 28, 2016, are fully vested and exercisable as of the date of this report.
SEC remarks
This Form 3 has been filed after March 18, 2026 but prior to April 20, 2026 in reliance on the temporary relief made available to the directors and officers of certain foreign private issuers by the Staff of the Securities and Exchange Commission in its no-action letter dated March 13, 2026.